The focus of this work was the characterisation of an impurity sometimes found in batches of the hydroxyxanthene colour additives D&C Red No. 27 (R27) and D&C Red No. 28 (R28, phloxine B). Countercurrent chromatography (CCC) was used to separate and concentrate the impurity (named here pHXCA) to ∼48% from a dye sample that contained ∼0.74% pHXCA. Pure pHXCA was obtained by collecting analytical HPLC-separated fractions from multiple injections of the CCC-concentrated sample. Various NMR and mass spectral techniques were used to determine the structure of pHXCA. In particular, the presence of a 35/37Cl isotope shift in the 13C NMR spectrum pointed to the location of the C-Cl bond specific to pHXCA and facilitated identification of its structure as 1-carboxy-7-bromo-6-hydroxy-2,3,4,5-tetrachloroxanthone. Significantly, that structure was different from the one erroneously reported by other researchers. A rapid screening of 18 dye batches (R27, n = 13; R28, n = 5) representing nine manufacturers, revealed that 12 batches contained pHXCA, with levels that ranged from 0.0009 to 0.182%. A side reaction during the manufacture of R27/28 in which a bromine atom is replaced with a chlorine atom in a closely related contaminant is suggested as the potential basis of pHXCA formation.
No takes yet. Share an insight, caveat, or question.
Weisz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: